Villaren, Ricamae .
HRN: 27-65-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFUROXIME 1.5GM (VIAL)
09/25/2025
09/26/2025
IV
1.5g
Q8 X 3 Doses
Uti
Checking Initial Appropriateness
09/26/2025
CEFUROXIME 500MG (TAB)
09/26/2025
10/02/2025
PO
500mg
BID
UTI
Checking Initial Appropriateness